APA (7th ed.) Citation

Schram, A., Goto, K., Kim, D., Macarulla, T., Hollebecque, A., O’Reilly, E. M., . . . Drilon, A. (2025). Efficacy of zenocutuzumab in NRG1 fusion-positive cancer. The New England journal of medicine, 392(6), . https://doi.org/10.1056/NEJMoa2405008

Chicago Style (17th ed.) Citation

Schram, Alison, et al. "Efficacy of Zenocutuzumab in NRG1 Fusion-positive Cancer." The New England Journal of Medicine 392, no. 6 (2025). https://doi.org/10.1056/NEJMoa2405008.

MLA (9th ed.) Citation

Schram, Alison, et al. "Efficacy of Zenocutuzumab in NRG1 Fusion-positive Cancer." The New England Journal of Medicine, vol. 392, no. 6, 2025, https://doi.org/10.1056/NEJMoa2405008.